These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7994617)

  • 21. Hapten design for the generation of catalytic antibodies.
    Thomas NR
    Appl Biochem Biotechnol; 1994; 47(2-3):345-72. PubMed ID: 7944348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Directed evolution governed by controlling the molecular recognition between an abzyme and its haptenic transition-state analog.
    Takahashi-Ando N; Kakinuma H; Fujii I; Nishi Y
    J Immunol Methods; 2004 Nov; 294(1-2):1-14. PubMed ID: 15604011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel monoclonal antibody with catalytic activity against beta human chorionic gonadotropin.
    Mirshahi M; Shamsipour F; Mirshahi T; Khajeh K; Naderi-Manesh H
    Immunol Lett; 2006 Jul; 106(1):57-62. PubMed ID: 16759712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simple method for selecting catalytic monoclonal antibodies that exhibit turnover and specificity.
    Tawfik DS; Zemel RR; Arad-Yellin R; Green BS; Eshhar Z
    Biochemistry; 1990 Oct; 29(42):9916-21. PubMed ID: 2271630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toward bifunctional antibody catalysis.
    Kikuchi K; Hannak RB; Guo MJ; Kirby AJ; Hilvert D
    Bioorg Med Chem; 2006 Sep; 14(18):6189-96. PubMed ID: 16782349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigations into the development of catalytic activity in anti-acetylcholinesterase idiotypic and anti-idiotypic antibodies.
    Johnson G; Moore SW
    J Mol Recognit; 2009; 22(3):188-96. PubMed ID: 19051205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody-mediated catalysis: induction and therapeutic relevance.
    Mahendra A; Sharma M; Rao DN; Peyron I; Planchais C; Dimitrov JD; Kaveri SV; Lacroix-Desmazes S
    Autoimmun Rev; 2013 Apr; 12(6):648-52. PubMed ID: 23207286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of an antibody-catalysed allylic isomerization.
    Gonçalves O; Dintinger T; Lebreton J; Blanchard D; Tellier C
    Biochem J; 2000 Mar; 346 Pt 3(Pt 3):691-8. PubMed ID: 10698695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune recognition, antigen design, and catalytic antibody production.
    Tramontano A
    Appl Biochem Biotechnol; 1994; 47(2-3):257-73; discussion 273-5. PubMed ID: 7944342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Probing the importance of second sphere residues in an esterolytic antibody by phage display.
    Arkin MR; Wells JA
    J Mol Biol; 1998 Dec; 284(4):1083-94. PubMed ID: 9837728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystal structures of the free and liganded form of an esterolytic catalytic antibody.
    Wedemayer GJ; Wang LH; Patten PA; Schultz PG; Stevens RC
    J Mol Biol; 1997 May; 268(2):390-400. PubMed ID: 9159478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression improvement and mechanistic study of the retro-Diels-Alderase catalytic antibody 10F11 by site-directed mutagenesis.
    Zheng L; Goddard JP; Baumann U; Reymond JL
    J Mol Biol; 2004 Aug; 341(3):807-14. PubMed ID: 15288788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Catalytic autoantibodies as a new molecular instrument in rheumatological practice].
    Khitrov AN; Mal'tsev KA; Vvedenskaia OIu; Ponomarenko NA; Isaeva MA; Kimova MV; Tret'iak EB; Shogenov ZS; Alekberova ZS; Gabibov AG; Suchkov SV
    Ter Arkh; 2006; 78(6):59-66. PubMed ID: 16881365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of functionally important residues in the pyridoxal-5'-phosphate-dependent catalytic antibody 15A9.
    Mouratou B; Stetefeld J
    Biochemistry; 2004 Jun; 43(21):6612-9. PubMed ID: 15157094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catalytic antibodies (abzymes) induced by stable transition-state analogs.
    Nevinsky GA; Semenov DV; Buneva VN
    Biochemistry (Mosc); 2000 Nov; 65(11):1233-44. PubMed ID: 11112839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crossreactivity, efficiency and catalytic specificity of an esterase-like antibody.
    Gigant B; Charbonnier JB; Eshhar Z; Green BS; Knossow M
    J Mol Biol; 1998 Dec; 284(3):741-50. PubMed ID: 9826512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspects of antibody-catalyzed primary amide hydrolysis.
    Titmas RC; Angeles TS; Sugasawara R; Aman N; Darsley MJ; Blackburn G; Martin MT
    Appl Biochem Biotechnol; 1994; 47(2-3):277-90; discussion 291-2. PubMed ID: 7944343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tech.Sight. Antibody design by man and nature.
    Wentworth P
    Science; 2002 Jun; 296(5576):2247-9. PubMed ID: 12077422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An improved rapid method for selecting monoclonal antibodies with high catalytic activities.
    Yuan YR; Yang BH; Ji YY
    J Protein Chem; 1997 Nov; 16(8):733-8. PubMed ID: 9365921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and synthesis of an alpha,alpha-difluorophosphinate hapten for antibody-catalyzed hydrolysis of organophosphorus nerve agents.
    Vayron P; Renard PY; Valleix A; Mioskowski C
    Chemistry; 2000 Mar; 6(6):1050-63. PubMed ID: 10785826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.